Pharmaceuticals
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Trend Stats
1-Month Return
+10.68%
3-Month Return
+7.56%
12-Month Return
+29.19%
Volatility Score
1.7
RSI
67.6
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Pharmaceuticals
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $1.1T | +56.60% | +29.97% | +14.07% | 3.3 | Up | Up |
| JNJ | Johnson&Johnson | $633B | +72.82% | +8.85% | +18.01% | 2.2 | Up | Up |
| ABBV | AbbVie | $461B | +42.42% | +26.05% | +21.20% | 2.6 | Up | Up |
| MRK | Merck | $320B | +65.44% | +7.96% | +12.83% | 2.7 | Up | Up |
| NVS | Novartis Sp ADR | $305B | +35.14% | +3.81% | +11.44% | 2.0 | Up | Up |
| AZN | ASTRAZENECA | $303B | +185.89% | -4.10% | +9.97% | 2.3 | Up | Up |
| NVO | Nordisk Sp ADR-B | $223B | -23.69% | +36.37% | +17.50% | 2.9 | Up | Up |
| PFE | Pfizer | $139B | +2.52% | -12.71% | -4.81% | 2.4 | Down | Down |
| BMY | Bristol-MyersSqu | $119B | +29.84% | -1.37% | +7.94% | 2.5 | Up | Up |
| GSK | GSK Sp ADR | $107B | +45.85% | -4.48% | +9.51% | 2.2 | Up | Up |
| SNY | SANOFI SP ADR | $103B | -5.69% | -4.88% | +0.84% | 2.4 | Down | Down |
| MCK | Mckesson | $92B | +9.76% | -10.98% | +6.72% | 2.6 | Neutral | Down |
| COR | Cencora | $58B | +0.85% | -8.50% | +11.96% | 2.4 | Up | Down |
| TAK | TAKEDA PHARM SP ADR | $53B | +13.70% | -10.51% | +10.47% | 1.7 | Up | Up |
| HLN | Haleon Sp ADR | $43B | -2.30% | +0.23% | +12.87% | 1.9 | Up | Neutral |
| TEVA | TEVAPHARMIND SP ADR | $40B | +103.64% | +15.16% | +4.72% | 3.5 | Neutral | Up |
| ZTS | Zoetis-A | $31B | -52.28% | -36.30% | -2.08% | 3.6 | Down | Down |
| VTRS | Viatris | $19B | +86.25% | +25.17% | +6.44% | 2.8 | Up | Up |
| JAZZ | Jazz Pharmaceuti | $15B | +122.45% | +30.23% | +7.67% | 2.9 | Up | Up |
| AXSM | Axsome Therapeut | $13B | +131.71% | +44.99% | +9.97% | 3.8 | Up | Up |
| ELAN | ELANC ANIML HLTH | $12B | +70.77% | +8.32% | +5.80% | 4.2 | Up | Up |
| CORT | Corcept Therapeu | $9.7B | +24.82% | +112.31% | +26.70% | 4.2 | Up | Up |
| OGN | Organon | $3.6B | +37.25% | +113.37% | +1.27% | 0.4 | Neutral | Up |
| BHC | BAUSCH HEALTH | $1.8B | -30.59% | -8.41% | -2.20% | 5.4 | Down | Down |
| PRGO | Perrigo | $1.5B | -56.02% | +4.21% | +5.35% | 5.0 | Neutral | Down |
| 0 | 0 | 0 | 0 | Bullish | Bullish |
